|
MIOS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.840160E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.857100E-03 |
| Normal-vs-Stage2 |
3.584600E-03 |
| Normal-vs-Stage3 |
8.640000E-02 |
| Normal-vs-Stage4 |
5.898000E-03 |
| Stage1-vs-Stage2 |
5.032400E-02 |
| Stage1-vs-Stage3 |
7.731400E-01 |
| Stage1-vs-Stage4 |
2.264000E-01 |
| Stage2-vs-Stage3 |
4.897800E-02 |
| Stage2-vs-Stage4 |
2.824600E-01 |
| Stage3-vs-Stage4 |
2.112000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.023600E-04 |
| Normal-vs-AfricanAmerican |
8.048300E-02 |
| Normal-vs-Asian |
2.601600E-01 |
| Caucasian-vs-AfricanAmerican |
2.239800E-01 |
| Caucasian-vs-Asian |
6.577800E-01 |
| AfricanAmerican-vs-Asian |
8.698800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.996540E-04 |
| Normal-vs-Female |
9.343300E-03 |
| Male-vs-Female |
2.760400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.745800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.643210E-03 |
| Normal-vs-Age(61-80Yrs) |
2.409900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.423600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.595590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.038390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.999800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.181000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.165400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.240350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.762800E-01 |
| Normal-vs-Grade 2 |
1.736300E-03 |
| Normal-vs-Grade 3 |
1.315810E-03 |
| Normal-vs-Grade 4 |
1.011590E-01 |
| Grade 1-vs-Grade 2 |
5.171200E-01 |
| Grade 1-vs-Grade 3 |
3.108400E-01 |
| Grade 1-vs-Grade 4 |
5.603800E-01 |
| Grade 2-vs-Grade 3 |
5.379600E-01 |
| Grade 2-vs-Grade 4 |
9.269800E-01 |
| Grade 3-vs-Grade 4 |
6.356200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.386050E-04 |
| Normal-vs-ccB subtype |
3.004200E-02 |
| ccA subtype-vs-ccB subtype |
2.560000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.201350E-03 |
| Normal-vs-N1 |
3.304200E-01 |
| N0-vs-N1 |
8.854400E-01 |
|
|
